Consun Pharma shuffles board, appoints new CFO

Consun Pharmaceutical Group (HKEX:1681) has announced a series of changes to its board and executive team. Ms. Chen Yujun has resigned as an independent non-executive director and chairlady of the audit committee, replaced by Mr. Li Zhuoguang, who also joins the nomination, remuneration, and ESG committees. Simultaneously, Mr. Fang Peicheng steps down as Chief Financial Officer, with Ms. Chen appointed as the new CFO. Mr. Li will receive an annual director's fee of RMB 200,000. The changes are effective February 24, 2025. Consun has expressed gratitude to both Ms. Chen and Mr. Fang for their contributions to the company.